Hopkins HS, Gelenberg AJ: Treatment of bipolar disorder: How far have we come?Psychopharm Bull30:27-35, 1994
2.
American Psychiatric Association:Practice guideline for the treatment of patients with bipolar disorderAm J Psychiatry151:1-36, 1994 (suppl)
3.
Coppen A., Abou-Saleh MT: Lithium therapy: From clinical trials to practical managementActa Psychiatr Scand78:754-762, 1988
4.
Chou Jcy: Recent advances in treatment of acute maniaJ Clin Psychopharmacol11:3-21, 1991
5.
Small JG: Anticonvulsants in affective disordersPsychopharmacol Bull26:25-36, 1990
6.
Post R.: Non-lithium treatment for bipolar disorderJ Clin Psychiatry51:9-16, 1990 [suppl 8]
7.
Ballenger JC : The use of anticonvulsants in manic-depressive illnessJ Clin Psychiatry49:21-24, 1988 [suppl 11]
8.
Schou M.: Lithium prophylaxis: Myths and realitiesAm J Psychiatry146:573-576, 1989
9.
Calabrese JR , Woyshville MJ: A medication algorithm for treatment of bipolar rapid cycling?J Clin Psychiatry56:11-18, 1995 [suppl 3]
10.
Coxhead N., Silverstone T., Cookson J.: Carbamazepine versus lithium in the prophylaxis of bipolar affective disorderActa Psychiatry Scand85:114-118, 1992
11.
Small JG, Klapper MH, Milstein V., et al: Carbamazepine compared with lithium in the treatment of maniaArch Gen Psychiatry48:915-921, 1991
12.
Bowden CL, McElroy SL: History of the development of valproate for treatment of bipolar disorderJ Clin Psychiatry56:3-5, 1995 [suppl 3]
13.
Brown R.: U.S. experience with valproate in manic depressive illness: A multicenter trialJ Clin Psychiatry50:13-16, 1989 (suppl 3)
14.
Pope HG, McElroy SL, Keck PE, Hudson JI: Valproate in the treatment of acute maniaArch Gen Psychiatry48:62-68, 1991
15.
Freeman TW, Clothier JL, Pazzaglia P., et al : A double-blind comparison of valproate and lithium in the treatment of acute maniaAm J Psychiatry149:108-111, 1992
16.
Bowden CL, Brugger AM, Swann AC, et al: Efficacy of divalproex vs lithium and placebo in the treatment of maniaJAMA271:918-924,1994
17.
Calabrese JR , Markovitz PJ, Kimmel SE, Wagner SC: Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patientsJ Clin Psychopharmacol12:53S-56S, 1992
18.
Hayes S.: Long-term use of valproate in primary psychiatric disordersJ Clin Psychiatry50:35-39,1989 [suppl 3]
19.
Chouinard G. : The use of benzodiazepines in the treatment of manic-depressive illnessJ Clin Psychiatry49:15-19, 1988 (suppl 11)
20.
Sachs GS, Rosenbaum JF, Jones L.: Adjunctive clonazepam for maintenance treatment of bipolar affective disorderJ Clin Psychopharmacol10:42-47, 1990
21.
Bradwejn J. , Shriqui C., Koszycki D., Meterissian G.: Double-blind comparison of the effects of clonazepam and lorazepam in acute maniaJ Clin Psychopharmacol10:403-408, 1990
22.
Keck PE, McElroy SL, Strakowski SM, West SA: Pharmacologic treatment of schizoaffective disorderPsychopharmacology114:529-538, 1994
23.
McElroy SL, Keck PE: Treatment guidelines or valproate in bipolar disorder and schizoaffective disordersCan J Psychiatry38:S62-S66, 1993
24.
Okuma T., Yamashita R., Takahashi H., et al : A double-blind study of adjunctive carbamazepine versus placobo on excited states of schizophrenic and schizoaffective disordersActa Psychiatry Scand80:250-259, 1989
25.
Klein E., Bental E., Lerer B., Belmaker RH: Carbamazepine and haloperidol versus placobo and haloperidol in excited psychosesArch Gen Psychiatry41:165-170, 1984
26.
Moller HJ, Kissling, Riehl T, et al: Double-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidolProg Neuro-Psychopharmacol Biol Psychiatry13:127-136, 1989
27.
Keck PE, McElroy SL, Friedman LM: Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromesJ Clin Psychopharmacol12:36S-41S, 1992
28.
Jacobsen FM : Low-dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders, and premenstral syndromeJ Clin Psychiatry54:229-234, 1993
29.
Deltito JA: The effect of valproate on bipolar spectrum temperamental disordersJ Clin Psychiatry54:300-304, 1993
30.
Roy-Byrne PP , Ward NG, Donnelly PJ: Valproate in anxiety and withdrawal syndromesJ Clin Psychiatry50:44-48, 1989 [suppl 3]
31.
Wilder BJ: Pharmacokinetics of valproate and carbamazepineJ Clin Psychopharmacol12:64S-68S, 1992
32.
Levy RH, Kerr BM: Clinical pharmacokinetics of carbamazepineJ Clin Psychiatry49:58-61, 1988 [suppl 4]
33.
Potter WZ, Ketter TA: Pharmacological issues in the treatment of bipolar disorder: Focus on mood stabilizing compoundsCan J Psychiatry38:S51-S56, 1993 [suppl 2]
34.
Davis R., Peters DH, McTavish D.: Valproic acid: A reappraisal of its pharmacological properties and clinical efficacy in epilepsyDrugs47:332-372, 1994
35.
Gerner RH, Stanton A.: Algorithm for patient management of acute manic states: Lithium, valproate, or carbamazepine?J Clin Psychopharmacol12:57S-63S, 1992
36.
Suppes T., Baldessarini RJ, Faedda GL, Tohen M.: Risk of recurrance following discontinuation of lithium treatment in bipolar disorderArch Gen Psychiatry48:1082-1088, 1991
37.
Suppes T., Baldessarini RJ, Faedda GL, et al: Discontinuation of maintenance treatment in bipolar disorder: Risks and implicationsHarvard Rev Psychiatry1:131-144, 1993
38.
Basco MR: Compliance with pharmacotherapy in mood disordersPsychiatric Ann25:269-279, 1995
39.
Camfield P. , Camfield C., Dooley J., et al: Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful valueCMAJ140:1303-1305, 1989
40.
Pellock JM, Willmore LJ: A rational guide to routine blood monitoring in patients receiving antiepileptic drugsNeurology41:961-964, 1991
41.
Wyllie E., Wyllie R.: Routine laboratory monitoring for serious adverse effects of antiepileptic medicationsThe controversy. Epilepsia35:S74-S79, 1991 [suppl 5]
42.
McElroy SL, Keck PE, Pope HG, Hudson JI: Valproate in the treatment of bipolar disorder: Literature review and clinical guidelinesJ Clin Psychiatry12:42S-52S, 1992
